Interferon γ Expressing Mucosal Cells in Pediatric Chronic Inflammatory Bowel Disease

Area of Science:

• Gastroenterology
• Immunology
• Pathology

Background:

• Crohn's disease (CD) and ulcerative colitis (UC) are inflammatory bowel diseases with distinct treatments and prognoses.
• Differentiating CD and UC can be challenging due to overlapping clinical and histological features.
• Aberrations in gastrointestinal mucosal inflammatory cells are implicated in CD and UC pathogenesis.

Purpose of the Study:

• To investigate the diagnostic utility of Interferon gamma (IFNγ) immunohistochemical expression in differentiating pediatric CD and UC.
• To assess IFNγ expression in various gastrointestinal mucosal sites (stomach, duodenum, terminal ileum, colon).

Main Methods:

• Automated assessment of IFNγ-positive mucosal cells in archival GI biopsies from a pediatric cohort.
• Comparison of IFNγ expression between CD, UC, and normal controls across different gastrointestinal segments.

Main Results:

• IFNγ-positive cells were elevated in the colon of both CD and UC patients compared to controls.
• IFNγ-positive cells were increased in the ileum of CD patients compared to controls and UC patients.
• IFNγ abundance did not correlate with active inflammation, suggesting it's an independent marker.

Conclusions:

• IFNγ immunohistochemistry shows potential as a biomarker for differentiating CD and UC, particularly in the ileum.
• Significant overlap in IFNγ expression between CD, UC, and normal tissues suggests limited clinical utility in routine diagnosis.
• Further research is warranted to explore IFNγ's role in specific cases, such as indeterminate inflammatory bowel disease.